Hims & Hers Health, Inc. (NYSE: HIMS) reported Q1 EPS of $0.20, $0.03 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $586 million versus the consensus estimate of $538.9 million.

GUIDANCE:

Hims & Hers Health, Inc. Affirms full year FY2025 revenue of $2.3-2.4 billion, versus the consensus of $2.32 billion. Raises Adjusted EBITDA guidance to a range of $295 million to $335 million

Hims & Hers Health, Inc. sees FY2025 revenue of $530-550 billion, versus the consensus of $564.5 billion. Adjusted EBITDA of $65 million to $75 million, reflecting an Adjusted EBITDA margin of 12% to 14%.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.